Molina Investors Urged to Act as December 2 Lead‑Plaintiff Deadline Nears in Securities Suit

Overview

• Investors who bought Molina securities between February 5 and July 23, 2025 face a December 2, 2025 deadline to move for lead‑plaintiff status.
• The complaint claims the company failed to disclose worsening medical cost trend assumptions, a mismatch between premium rates and costs, and reliance on unusually low utilization across key services.
• Molina reduced 2025 guidance and reported second‑quarter results on July 23, 2025, after which the stock fell $32.03, or 16.84%, to close at $158.22 on July 24.
• The case, Hindlemann v. Molina Healthcare, Inc., is pending in the U.S. District Court for the Central District of California, and no class has been certified.
• Law firms including Glancy Prongay & Murray, the Rosen Law Firm, and Kahn Swick & Foti are soliciting affected investors and offering contingency‑fee representation.